Emily A Kibble

Broad-spectrum in vitro activity of macrophage infectivity potentiator inhibitors against Gram-negative bacteria and Leishmania major

P. Myler, U. Holzgrabe, C. Bond, 2022, The Journal of antimicrobial chemotherapy.

Anti-Virulence Therapeutic Approaches for Neisseria gonorrhoeae

K. Stubbs, M. Sarkar-Tyson, C. Kahler, 2021, Antibiotics.

Targeting protein folding; a novel approach for the treatment of pathogenic bacteria.

U. Holzgrabe, M. Sarkar-Tyson, N. Bzdyl, 2020, Journal of medicinal chemistry.

Enzyme targets for drug design of new anti-virulence therapeutics.

K. Stubbs, A. Vrielink, M. Sarkar-Tyson, 2018, Current opinion in structural biology.

Macrophage infectivity potentiator protein, a peptidyl prolyl cis-trans isomerase, essential for Coxiella burnetii growth and pathogenesis

Nichollas E. Scott, U. Holzgrabe, C. Bond, 2023, PLoS pathogens.

The Detroit 562 Pharyngeal Immortalized Cell Line Model for the Assessment of Infectivity of Pathogenic Neisseria sp.

M. Sarkar-Tyson, G. Coombs, C. Kahler, 2019, Methods in molecular biology.

Analysis of Structure-Activity Relationships of Novel Inhibitors of the Macrophage Infectivity Potentiator (Mip) Proteins of Neisseria meningitidis, Neisseria gonorrhoeae, and Burkholderia pseudomallei.

U. Holzgrabe, M. Sarkar-Tyson, N. Bzdyl, 2023, Journal of Medicinal Chemistry.